BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

11065

537291

NATHBIOGEN

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

NATH BIO-GENES (I) LTD performance

Today’s low

Today’s high

₹ 156.15 ₹ 166.88
₹ 157.31

52 week low

52 week high

₹ 137.55 ₹ 264.31
₹ 157.31

Open Price

₹ 157.90

Prev. Close

₹ 157.82

Volume (Shares)

43724.00

Total traded value

₹ 68.78

Upper Circuit

₹ 189.38

Lower Circuit

₹ 126.25

info

NATH BIO-GENES (I) LTD Share Price Update

As of the latest trading session, NATH BIO-GENES (I) LTD share price is currently at ₹ 157.61, which is down by ₹ -0.21 from its previous closing. Today, the stock has fluctuated between ₹ 156.15 and ₹ 166.88. Over the past year, NATH BIO-GENES (I) LTD has achieved a return of -24.75 %. In the last month alone, the return has been 2.36 %. Read More...

NATH BIO-GENES (I) LTD fundamentals


  • Market cap (Cr)

    299.52

  • P/E Ratio (TTM)

    7.02

  • Beta

    1.10

  • Book Value / share

    338.51

  • Return on equity

    6.79%

  • EPS (TTM)

    21.94

  • Dividend yield

    1.27%

  • Net profit/quarter (Cr)

    4.71

info icon alternate text
  • Market cap (Cr)

    296.65

  • P/E Ratio (TTM)

    7.06

  • Beta

    1.10

  • Book Value / share

    341.33

  • Return on equity

    6.79%

  • EPS (TTM)

    21.89

  • Dividend yield

    1.27%

  • Net profit/quarter (Cr)

    4.71

info icon alternate text

NATH BIO-GENES (I) LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 49.37
Operating Expense 48.62
Net Profit 4.71
Net Profit Margin (%) 9.54
Earnings Per Share (EPS) 2.12
EBITDA 7.22
Effective Tax Rate (%) 13.12
Particulars DEC 2024 (Values in Cr)
Revenue 36.87
Operating Expense 33.56
Net Profit 2.66
Net Profit Margin (%) 7.21
Earnings Per Share (EPS) 1.34
EBITDA 7.99
Effective Tax Rate (%) 30.07
Particulars SEP 2024 (Values in Cr)
Revenue 32.19
Operating Expense 29.39
Net Profit 2.89
Net Profit Margin (%) 8.97
Earnings Per Share (EPS) 1.46
EBITDA 6.63
Effective Tax Rate (%) -1.04
Particulars JUN 2024 (Values in Cr)
Revenue 243.88
Operating Expense 209.88
Net Profit 33.89
Net Profit Margin (%) 13.89
Earnings Per Share (EPS) 17.77
EBITDA 37.20
Effective Tax Rate (%) 0.73
Particulars MAR 2024 (Values in Cr)
Revenue 43.04
Operating Expense 40.60
Net Profit 3.21
Net Profit Margin (%) 7.45
Earnings Per Share (EPS) 2.18
EBITDA 4.91
Effective Tax Rate (%) 21.60
Particulars MAR 2025 (Values in Cr)
Revenue 362.31
Operating Expense 323.45
Net Profit 42.14
Net Profit Margin (%) 11.63
Earnings Per Share (EPS) 22.00
EBITDA 57.01
Effective Tax Rate (%) 4.54
Particulars MAR 2024 (Values in Cr)
Revenue 332.62
Operating Expense 294.60
Net Profit 40.18
Net Profit Margin (%) 12.07
Earnings Per Share (EPS) 21.63
EBITDA 51.03
Effective Tax Rate (%) 5.04
Particulars MAR 2023 (Values in Cr)
Revenue 301.29
Operating Expense 265.53
Net Profit 35.17
Net Profit Margin (%) 11.67
Earnings Per Share (EPS) 18.50
EBITDA 49.44
Effective Tax Rate (%) 3.16
Particulars MAR 2022 (Values in Cr)
Revenue 278.36
Operating Expense 254.64
Net Profit -67.17
Net Profit Margin (%) -24.13
Earnings Per Share (EPS) -35.43
EBITDA -49.53
Effective Tax Rate (%) -6.24
Particulars MAR 2021 (Values in Cr)
Revenue 307.56
Operating Expense 252.48
Net Profit 55.66
Net Profit Margin (%) 18.09
Earnings Per Share (EPS) 29.29
EBITDA 68.38
Effective Tax Rate (%) 1.92
Particulars MAR 2024 (Values in Cr)
Book Value / Share 320.94
ROE % 6.70
ROCE % 7.23
Total Debt to Total Equity 0.18
EBITDA Margin 16.24
Particulars MAR 2023 (Values in Cr)
Book Value / Share 301.61
ROE % 6.28
ROCE % 7.03
Total Debt to Total Equity 0.18
EBITDA Margin 16.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 285.16
ROE % 4.38
ROCE % 5.64
Total Debt to Total Equity 0.17
EBITDA Margin 14.04
Particulars MAR 2013 (Values in Cr)
Book Value / Share 35.91
ROE % 22.77
ROCE % 23.41
Total Debt to Total Equity 0.29
EBITDA Margin 14.87
Particulars MAR 2012 (Values in Cr)
Book Value / Share 28.57
ROE % 20.12
ROCE % 18.67
Total Debt to Total Equity 0.24
EBITDA Margin 12.57
Particulars MAR 2024 (Values in Cr)
Book Value / Share 321.33
ROE % 6.79
ROCE % 7.31
Total Debt to Total Equity 0.18
EBITDA Margin 16.41
Particulars MAR 2023 (Values in Cr)
Book Value / Share 301.70
ROE % 6.31
ROCE % 7.06
Total Debt to Total Equity 0.18
EBITDA Margin 16.44
Particulars MAR 2022 (Values in Cr)
Book Value / Share 285.19
ROE % 4.12
ROCE % 5.32
Total Debt to Total Equity 0.17
EBITDA Margin 14.05
Particulars MAR 2021 (Values in Cr)
Book Value / Share 322.71
ROE % 9.51
ROCE % 9.74
Total Debt to Total Equity 0.15
EBITDA Margin 22.25
Particulars MAR 2020 (Values in Cr)
Book Value / Share 293.42
ROE % 9.48
ROCE % 9.21
Total Debt to Total Equity 0.12
EBITDA Margin 20.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 77.40
Total Assets 880.23
Total Liabilities 880.23
Total Equity 609.91
Share Outstanding 19004000
Price to Book Ratio 0.54
Return on Assets (%) 4.50
Return on Capital (%) 5.5
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 37.99
Total Assets 792.79
Total Liabilities 792.79
Total Equity 573.15
Share Outstanding 19004000
Price to Book Ratio 0.47
Return on Assets (%) 4.41
Return on Capital (%) 5.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.18
Total Assets 739.48
Total Liabilities 739.48
Total Equity 541.92
Share Outstanding 19004000
Price to Book Ratio 0.75
Return on Assets (%) -9.11
Return on Capital (%) -10.61
Particulars MAR 2013 (Values in Cr)
Cash & Short Term Investments 2.48
Total Assets 158.28
Total Liabilities 158.28
Total Equity 57.47
Share Outstanding 16004000
Price to Book Ratio 0.00
Return on Assets (%) 7.42
Return on Capital (%) 15.49
Particulars MAR 2012 (Values in Cr)
Cash & Short Term Investments 3.29
Total Assets 119.95
Total Liabilities 119.95
Total Equity 45.72
Share Outstanding 16004000
Price to Book Ratio 0.00
Return on Assets (%) 7.67
Return on Capital (%) 16.83
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 75.50
Total Assets 877.08
Total Liabilities 877.08
Total Equity 610.65
Share Outstanding 19004000
Price to Book Ratio 0.54
Return on Assets (%) 4.58
Return on Capital (%) 5.59
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 37.98
Total Assets 792.97
Total Liabilities 792.97
Total Equity 573.35
Share Outstanding 19004000
Price to Book Ratio 0.47
Return on Assets (%) 4.43
Return on Capital (%) 5.18
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.16
Total Assets 739.53
Total Liabilities 739.53
Total Equity 541.96
Share Outstanding 19004000
Price to Book Ratio 0.75
Return on Assets (%) -9.10
Return on Capital (%) -10.61
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 29.21
Total Assets 789.50
Total Liabilities 789.50
Total Equity 613.27
Share Outstanding 19004000
Price to Book Ratio 0.93
Return on Assets (%) 7.05
Return on Capital (%) 7.86
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 21.98
Total Assets 729.94
Total Liabilities 729.94
Total Equity 557.61
Share Outstanding 19004000
Price to Book Ratio 0.46
Return on Assets (%) 6.91
Return on Capital (%) 8.05
Particulars MAR 2024 (Values in Cr)
Net Income 41.56
Cash from Operations 74.93
Cash from Investing -27.40
Cash from Financing -7.77
Net change in Cash 39.41
Free Cash Flow 101.70
Particulars MAR 2023 (Values in Cr)
Net Income 36.16
Cash from Operations 39.28
Cash from Investing -2.88
Cash from Financing -1.66
Net change in Cash 33.81
Free Cash Flow 41.76
Particulars MAR 2022 (Values in Cr)
Net Income -63.43
Cash from Operations 19.92
Cash from Investing -19.85
Cash from Financing -22.23
Net change in Cash -25.03
Free Cash Flow 21.02
Particulars MAR 2024 (Values in Cr)
Net Income 42.12
Cash from Operations 75.06
Cash from Investing -27.39
Cash from Financing -9.80
Net change in Cash 37.51
Free Cash Flow 101.83
Particulars MAR 2023 (Values in Cr)
Net Income 36.31
Cash from Operations 39.28
Cash from Investing -2.88
Cash from Financing -1.66
Net change in Cash 33.81
Free Cash Flow 41.76
Particulars MAR 2022 (Values in Cr)
Net Income -63.38
Cash from Operations 19.92
Cash from Investing -19.86
Cash from Financing -22.23
Net change in Cash -25.04
Free Cash Flow 21.03
Particulars MAR 2021 (Values in Cr)
Net Income 56.75
Cash from Operations 1.41
Cash from Investing -10.28
Cash from Financing 16.40
Net change in Cash 7.23
Free Cash Flow 12.96
Particulars MAR 2020 (Values in Cr)
Net Income 48.50
Cash from Operations 10.99
Cash from Investing -14.43
Cash from Financing 5.56
Net change in Cash 0.60
Free Cash Flow 15.23
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5469.20 60.56 41.03 131735.69 4506.50 / 6473.10
NESTLE INDIA LIMITED 2387.45 74.96 57.40 230187.70 2115.00 / 2777.00
FOODS & INNS LIMITED 89.63 27.16 1.28 658.02 75.20 / 165.70
HINDUSTAN UNILEVER LTD. 2322.55 52.36 11.04 545704.32 2136.00 / 3034.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5469.20 62.08 47.49 131735.69 4506.50 / 6473.10
COLGATE PALMOLIVE LTD. 2645.25 49.22 43.53 71947.00 2324.00 / 3893.00
NESTLE INDIA LIMITED 2387.45 74.31 55.90 230187.70 2115.00 / 2777.00
FOODS & INNS LIMITED 89.63 26.13 1.27 658.02 75.20 / 165.70

NATH BIO-GENES (I) LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
157.31 -0.32 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 160.40
  • 26 Days 158.60
  • 10 Days 160.70
  • 50 Days 160.00
  • 12 Days 160.30
  • 100 Days 168.10
  • 20 Days 159.00
  • 200 Days 180.30
158.66 PIVOT

First Support

156.16

First Resistance

160.32

Second Support

154.50

Second Resistance

162.82

Third Support

152.00

Third Resistance

164.48

RSI

49.19

ADX

17.28

MACD

1.78

Williams % R

-52.41

Commodity Channel Index (CCI)

4.62

Date

2025-04-29

Week

13772.00

Same Day

15199.00

Month

16218.00

1 Year

1.11

3 Year

1.02

Over 1 Month

2.36%

down

Over 1 Year

-24.75%

down

Over 3 Months

-6.48%

down

Over 3 Years

-11.98%

down

Over 6 Months

-14.38%

down

Over 5 Years

-8.57%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

NATH BIO-GENES (I) LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
50.24%
Promoter Holdings
45.59%
FII
0.21%
DII
3.94%
Promoter Shares(Pledge Percentage)
16.38%
Name Shares Category
Ashu Farms Llp 2598949.0 (13.68%) Shareholding of Promoter and Promoter Group
Akash Farms Llp 2326283.0 (12.24%) Shareholding of Promoter and Promoter Group
Mayo Farms Llp 1087339.0 (5.72%) Public Shareholding
Tapovan Farms Llp 984191.0 (5.18%) Public Shareholding
Aditya Birla Sun Life Trustee Private Limited A/c Adutya Birla Sun Life Pure Value Fund 737349.0 (3.88%) Public Shareholding
Emerald Seeds Private Limited 690000.0 (3.63%) Shareholding of Promoter and Promoter Group
Tingli Finvest Pvt Ltd 562360.0 (2.96%) Shareholding of Promoter and Promoter Group
Nath Industries Limited 532000.0 (2.8%) Shareholding of Promoter and Promoter Group
Barkha Farms Llp 522830.0 (2.75%) Shareholding of Promoter and Promoter Group
Nath Royal Ltd 494692.0 (2.6%) Shareholding of Promoter and Promoter Group
Madanlal Jawanmalji Jain 415881.0 (2.19%) Public Shareholding
Satpal Khattar 400000.0 (2.1%) Public Shareholding
Ferry Fax Farms Private Limited 307644.0 (1.62%) Shareholding of Promoter and Promoter Group
Pithambar Farms Private Limited 250000.0 (1.32%) Shareholding of Promoter and Promoter Group
Arati Farms Private Limited 202641.0 (1.07%) Shareholding of Promoter and Promoter Group
Nath Biotechnologies Ltd 101200.0 (0.53%) Shareholding of Promoter and Promoter Group
Prabha Farms Private Limited 75271.0 (0.4%) Shareholding of Promoter and Promoter Group
Agri-tech (india) Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Jeevan Investment & Finance Pvt Ltd 219.0 (0.0%) Shareholding of Promoter and Promoter Group
Paresh Farms Private Limited 374.0 (0.0%) Shareholding of Promoter and Promoter Group
Jeevanlata Nandkishor Kagliwal 293.0 (0.0%) Shareholding of Promoter and Promoter Group
Nandkishor Laxminarayan Kagliwal 146.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

NATH BIO-GENES (I) LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
04 Jul 2023 2.0 Final 30 Jun 2023 Equity shares
23 Jun 2022 2.0 Final 25 Jun 2022 Equity shares
18 Aug 2021 2.0 Final 22 Aug 2021 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
04 Jul 2023 2.0 Final 30 Jun 2023 Equity shares
23 Jun 2022 2.0 Final 25 Jun 2022 Equity shares
18 Aug 2021 2.0 Final 22 Aug 2021 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

NATH BIO-GENES (I) LTD Share Price

Nath Bio-Genes (India) Limited was originally incorporated in the name and style of 'Shivnath Farms Private Limited' as Private Limited Company which thereafter was converted into Public Limited Company on 13 September, 2000 under the name and style of Shivnath Farms Limited' and further changed from Shivnath Farms Limited to Nath Bio-Genes (India) Limited on March 05, 2001.

The Company stands as a distinguished leader in the Indian seed industry, leveraging over two decades of expertise in producing and distributing high-quality seeds to Indian farmers. The Company's robust research and development initiatives have yielded numerous acclaimed cotton seed varieties, noted for their resilience against viruses and weather fluctuations, as evidenced by their outstanding performance in ICAR trials. The Company's commitment to excellence is further demonstrated through its comprehensive extension programs designed to empower farmers. These initiatives include product awareness campaigns, crop demonstrations, agronomic input guidance, fertigation practices, and post-harvest management training.

As Nath Bio-Genes transitions from addressing food security to focusing on nutritional security, the Company is dedicated to bringing healthier seed varieties from farms to consumers' plates. This strategic shift underscores the ongoing mission to support farmers and contribute to overall well being of the population through innovative agricultural solutions.

Presently, the Company is engaged in the business of production, processing, and marketing of hybrid and GM seeds. The Company has a product into field crops, vegetable crops and plant nutrient supplements. The major processing plants are situated at Aurangabad (MS), and Munipalli, Nizamabad (TG).

In India, the company has nearly 16 business centres covering 131 territories & connecting with over 2,000 distributors, all across the country. The company has been presently venturing to newer geographies outside the country, possessing similar agronomical conditions as India. all set to spread its wings in other parts of Asia, Africa & the Middle East. The company has developed modern infrastructure facilities, biotech lab and seed technology lab. It has a wide dealers and distribution network of PAN India marketing & distribution network which is manned by technically and commercially skilled marketing team.

The Company produced several highly ranked cotton seeds in the country which have done well in the ICAR trials and stood the test of time with respect to various virus tolerance as well as improved yield in spite of weather fluctuations. It is the first seed company in Asia Pacific region to get ISO 9001 certificate. It's new launches Sanket and Daksh cotton seeds have been ranked among top 3 in most geographies and under various planting conditions. The consistent high rank achieved by company's new seeds gives reasonable confidence about it growing it's cotton seeds portfolio faster than the industry. The strategy is to provide farmers with a wide range of varieties of cotton seeds suitable for diverse climatic conditions while maintaining yield superiority.

The company has worked on de-risking it's business by having multiple growth drivers like paddy, vegetable seeds and plant nutrient in it's portfolio. The company established a network of over 15,000 farmers growing seeds. It has been awarded with the prestigious 'Vasantrao Naik Prathisthan Award' for its contribution for enhancing Agricultural Productivity amongst other rewards & recognition.

At present, the company has about 18 breeding and evaluation R&D Stations in different agro-climatic conditions. It has more than 300 acres of land dedicated to research and development, across the nation. It has collaboration with reputed International and National Centres of Excellence (NRCPB, CIMMYT, IRRI, ICRISAT Etc.) The company has a team of handpicked plant breeders and bio technologists, located at key R&D stations, across the country, guided by R&D veterans. It undertakes seed production in over 30,000 acres of land with about 25,000 loyal growers and 72 technically qualified organizers. The company assures that seeds of the highest quality reaches the processing centers by setting rigorous field standards and quality control checks throughout the seed production process.

The company has elaborate seed processing facilities with 10 Processing Plants located in Maharashtra and Andhra Pradesh. It has processing arrangements in Gujarat, Karnataka, Tamil Nadu, Madhya Pradesh and Rajasthan on custom basis. The seeds received
from growers are processed to achieve quality standards which surpass those prescribed by the regulatory authorities. All the plants are equipped with pre-cleaner, fine cleaner, grader, gravity separator, de-stoner, indented cylinder, treater, needle separator and packing machines which are fully automated. The company has independent facilities for ginning, de-linting, drying, processing, treating, packing and storage of seeds. The seed processing quality is taken to the next level by ensuring improvements in seed viability and prolonging the shelf life of seeds. All the packing material has best environmental barriers characteristics to guarantee optimal storage conditions for the seed.

The company's key function is to rigorously test products in various agro-climatic regions and compare the yield to benchmark products of competitors. The product undergoes a rigorous state gate screening process comprising six stages prior to commercial release. Seed Production and Disease Screening are an instrumental part of product development with testing spread across 40 locations, 8 centres and all agro-climatic zones of India. Besides, trials are conducted in three phases to thoroughly test the performance of products before recommending for a national launch. The three different phases of trials are MLT (Multi Location Trial), LST (Large scale Trial) and Demonstrations. For the Multi-level trials, the company have nearly eight stations - each at a different agro-climatic zone divided across the length and breadth of the country.

The Company launched two high performing new cotton hybrids seeds, Sanket and Daksh in 2019-20.

NBIL undertakes seed production in over 30,000 acres of land with about 25,000 loyal growers and 100 plus technically qualified organizers. Seed is produced in the states of Andhra Pradesh, Gujarat, Karnataka, Maharashtra, Rajasthan, Odisha, Uttar Pradesh, Madhya Pradesh, and Tamil Nadu which covers different agro-climatic zones of the country. The company assures that seeds of the highest quality reach its processing centres by setting rigorous field standards and quality control checks throughout the seed production process. A team of qualified production staff and quality personnel visit to monitor farms in order to ensure stringent controls. The foundation seed with highest genetic purity is sown in all crops.

In 2021-22, the Company launched four new products in different segments of hybrid paddy including Dhoom, Dhadak and Dhadak Gold.

In 2023-24, the Company further introduced two new organic fertilizers, WINALL granules and WINPRO GOLI, to the product basket by addressing the critical need for soil nutritional supplements. A Joint Venture with 90% stake holding as JV- Nath Bio-Genes CA LLC, Uzbekistan, was incorporated & registered in 2024.

Parent organization Indian Private
NSE symbol NATHBIOGEN
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Nath Bio-Genes (India) Ltd?

Answer Field

The share price of Nath Bio-Genes (India) Ltd for NSE is ₹ 157.61 and for BSE is ₹ 156.1.

What is the Market Cap of Nath Bio-Genes (India) Ltd?

Answer Field

The market cap of Nath Bio-Genes (India) Ltd for NSE is ₹ 2,99.52 Cr. and for BSE is ₹ 2,96.65 Cr. as of now.

What is the 52 Week High and Low of Nath Bio-Genes (India) Ltd?

Answer Field

The 52 Week High and Low of Nath Bio-Genes (India) Ltd for NSE is ₹ 264.31 and ₹ 137.55 and for BSE is ₹ 264.50 and ₹ 141.10.

How to Buy Nath Bio-Genes (India) Ltd share?

Answer Field

You can trade in Nath Bio-Genes (India) Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Nath Bio-Genes (India) Ltd?

Answer Field

The 1 year returns on the stock has been -23.74%.

What is the Current Share Price of Nath Bio-Genes (India) Ltd?

Answer Field

Nath Bio-Genes (India) Ltd share price is for NSE ₹ 157.61 & for BSE ₹ 156.1 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Nath Bio-Genes (India) Ltd Share?

Answer Field

The market cap of Nath Bio-Genes (India) Ltd for NSE ₹ 2,99.52 & for BSE ₹ 2,96.65 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Nath Bio-Genes (India) Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Nath Bio-Genes (India) Ltd share is 7.02.

What is the PB ratio of Nath Bio-Genes (India) Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Nath Bio-Genes (India) Ltd share is 338.51.

How to Buy Nath Bio-Genes (India) Ltd Share?

Answer Field

You can trade in Nath Bio-Genes (India) Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Nath Bio-Genes (India) Ltd Share on Bajaj Broking App?

Answer Field

To buy Nath Bio-Genes (India) Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Nath Bio-Genes (India) Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|